Endocardial vagal atrioventricular node stimulation in humans: Reproducibility on 18-month follow-up

Europace

Volumn 12, Issue 12, 2010, Pages 1719-1724

  Rossi, Pietro ^a   Bianchi, Stefano ^b   Valsecchi, Sergio ^c   Porcelli, Daniele ^b   Sgreccia, Fabrizio ^b   Lucifiero, Antonio ^b   Canonaco, Sergio ^c   Campoli, Massimiliano ^a   Malavasi, Mario ^d   Piccirillo, Gianfranco ^d   Quaglione, Raffaele ^d   Azzolini, Paolo ^b  

^a BELCOLLE HOSPITAL   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c Medtronic Italy ^*  (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atrial fibrillation; Atrioventricular node; Endocardial; Vagal stimulation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRIC POTENTIAL; ENDOCARDIUM; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIOVENTRICULAR NODE VAGAL STIMULATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ATRIUM SEPTUM; HEART PACING; HEART RATE; HEART RIGHT ATRIUM; HUMAN; IMPEDANCE; MALE; P WAVE; PRIORITY JOURNAL; REPRODUCIBILITY;

AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 78649368032     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq343     Document Type: Article

References (20)

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
2. Zhang Y, Mowrey KA, Zhuang S, Wallick DW, Popović ZB, Mazgalev TN. Optimal ventricular rate slowing during atrial fibrillation by feedback AV nodal-selective vagal stimulation. Am J Physiol Heart Circ Physiol 2002;282:H1102-10.
3. Schauerte P, Mischke K, Plisiene J, Waldmann M, Zarse M, Stellbrink C et al. Cath-eter stimulation ofcardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system. Circulation 2001;104:2430-5.
4. Quan KJ, Lee JH, Van Hare GF, Biblo LA, Mackall JA, Carlson MD. Identification and characterization of atrioventricular parasympathetic innervation in humans. J Cardiovasc Electrophysiol 2002;13:735-9.
5. Rossi P, Bianchi S, Barretta A, Della Scala A, Kornet L, De Paulis R et al. Post-operative atrial fibrillation management by selective epicardial vagal fat pad stimu-lation. J Interv Card Electrophysiol 2009;24:37-45.
6. Zhang Y, Yamada H, Bibevski S, Zhuang S, Mowrey KA, Wallick DW et al. Chronic atrioventricular nodal vagal stimulation: first evidence for long-term ventricular rate control in canine atrial fibrillation model. Circulation 2005;112:2904-11.
7. Bianchi S, Rossi P, Della Scala A, Kornet L Endocardial transcatheter stimulation of the AV nodal fat pad: stabilization of rapid ventricular rate response during atrial fibrillation in left ventricular failure. J Cardiovasc Electrophysiol 2009;20:103-5.
8. Bianchi S, Rossi P, Della Scala A, Kornet L, Pulvirenti R, Monari G et al. Atrioven-tricular (AV) node vagal stimulation by transvenous permanent lead implantation to modulate AV node function: safety and feasibility in humans. Heart Rhythm 2009;6:1282-6.
9. Mischke K, Zarse M, Schmid M, Gemein C, Hatam N, Spillner J et al. Chronic aug-mentation of the parasympathetic tone to the atrioventricular node: a nonthor-acotomy neurostimulation technique for ventricular rate control during atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:193-9.
10. Gemein C, Schauerte P, Hatam N, Rana OR, Saygili E, Meyer C et al. Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone. Europace 2009;11:1090-6.
11. Rossi P, Bianchi S, Monari G, Della Scala A, Porcelli D, Valsecchi S et al. Vagal tone augmentation to the atrioventricular node in humans: efficacy and safety of burst endocardial stimulation. Heart Rhythm 2010;7:683-9.
12. Zhou J, Scherlag BJ, Edwards J,Jackman WM, Lazzara R, Po SS. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglio-nated plexi. J Cardiovasc Electrophysiol 2007;18:83-90.
13. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK et al. The DAVID (dual chamber and VVI implantable defibrillator) II trial. J Am Coll Cardiol 2009;53:872-80.
14. Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N. Atrial septal pacing: a new approach to prevent atrial fibrillation. Pacing Clin Electrophysiol 2004;27: 850-4.
15. Porciani MC, Sabini A, Colella A, Michelucci A, Musilli N, Pieragnoli P et al. Intera-trial septum pacing avoids the adverse effect of interatrial delay in biventricular pacing: an echo-Doppler evaluation. Europace 2002;4:317-24.
16. Puglisi A, Gasparini M, Lunati M, Sassara M, Padeletti L, Landolina M et al. Persist-ent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol 2008;19:693-701.
17. Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N et al. Effect ofcardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006;114:18-25.
18. Knight BP, Desai A, Coman J, Faddis M, Yong P. Long-term retention of cardiac resynchronization therapy.JAm Coll Cardiol 2004;44:72-7.
19. Daubert JP, Zareba W, Cannom DS, Mc Nitt S, Rosero SZ, Wang P et al. Inap-propriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
20. Kamphuis HC, De Leeuw JR, Derksen R, Hauer R, Winnubst JA. A 12 month quality of life assessment of cardiac arrest survivors treated with or without an implantable cardioverter defibrillator. Europace 2002;4:417-25.